Navigation Links
Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Date:5/21/2009

- Bold and innovative marketing campaign will target women and highlight product's efficacy, ease of use and excellent tolerability -

CORONA, Calif., May 21 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, a leader in generic and specialty branded pharmaceuticals, announced today the launch of GELNIQUE(TM) (oxybutynin chloride) gel 10%, first and only topical gel for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency.

While GELNIQUE is approved for use in men as well as women, Watson has opted to target the active, female OAB patient in its marketing efforts. The GELNIQUE marketing campaign will highlight the power of control GELNIQUE offers to OAB patients rather than focusing, as traditional products have, on the predictable embarrassment and stigma associated with OAB.

"As the first and only topical gel for OAB, we believe that GELNIQUE provides physicians and their patients with an effective, easy first-line drug treatment option," said Paul Bisaro, Chief Executive Officer of Watson. "Because GELNIQUE is a first, we are launching our product with a unique promotional campaign, one that speaks to health care professionals and patients with language and images that are empowering. We believe we can successfully position this new treatment option in a way that differentiates our product, and our message in a category that has been dominated by big pharma's tired and traditional promotion for years."

OAB is characterized by a sudden, uncomfortable need to urinate with or without urge incontinence (urine leakage), and usually includes more frequent urination and nocturia (waking up at least once during the night to urinate). It affects as many as 34 million adults in the U.S. - more than diabetes or asthma. The U.S. OAB market currently exceeds $1.8 billion annually and continues to grow each year. More than an "inconven
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine news :

1. Watson-Marlow Releases Informative Video Featuring Showcased High Purity Pumps, Tubing and Fillers at Interphex 2009
2. Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
3. Watson Files FDA Applications for Generic Mucinex(R)
4. Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting
5. Companies Continue To Add Wellness Programs, Watson Wyatt/National Business Group On Health Survey Finds
6. Mark G. Watson Named Executive Director of Radiological Society of North America
7. Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
8. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
9. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
10. Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation
11. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...vehicles may reduce future disease burden, researc...News) -- Encouraging city dwellers to walk and bic...r public health benefits than increased used of lo..., The study compared the projected health effec...narios for London, England, and Delhi, India: bus...
(Date:11/27/2009)...h™ announced today that Spectrum Health (Gra...terprise orthopedic templating solution and its Tr... (PRWEB) November 27, 2009 -- Voyant Hea...rand Rapids, Michigan) has licensed its TraumaCad ...TraumaCad Extend workflow solution, to allow its o...
(Date:11/27/2009)...teractive anatomy education apps from Modality and...ciences learning opportunities for iPhone and iPod...s) November 27, 2009 -- Modality, Inc. and Lippi...Wolters Kluwer Health, today announced the availab...pp Store. Clemente’s Anatomy, Rohen’s ...
(Date:11/26/2009)...Americans living with diabetes will nearly double,...ion in 2034. Over the same period, spending on dia... to $336 billion, even with no increase in the pre...rsity of Chicago report in the December issue of ...tes covered by Medicare will rise from 8.2 million...
(Date:11/26/2009)...otional rollercoaster, study finds , , T...ear factor meets the jubilant sports fan. , A n...ose who root for the winning team -- enjoy the gre...ch and victory was in doubt, producing feelings of...anksgiving weekend as you,re glued to the TV set, ...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
...e-FirstCall/ - The Westaim Corporation,announced t...l western,Canadian construction services companies...posed reorganization agreement dated on,October 3,...hin 14 days of the mailing of the information circ...
... combination that included folic acid and vitamin ...l risk of cancer, including breast cancer, among w...ding to a study in the November 5 issue of JAMA ....fortification of the food supply with folic acid (...
...VION,PHARMACEUTICALS, INC. (OTC Bulletin Board: VI...ference call on Thursday, November 6, 2008 to,disc...e call will begin at 8:30 a.m. Eastern Time., To ... start of the call. When prompted for a pass code,...
...the possibility of,a failed ceasefire and renewed ...us humanitarian situation in the Democratic Republ...carrying out urgently needed,distributions of ther...fighting reignites," said Pierre Willems, Internat...
...n insulin pump to manage diabetes is more convenie...jections. That much, physicians already know. , ...d their primary caregivers is an important questio... lives," says Dr. Max Stachura, director of the Me...
...articipation in Upcoming Investor Conferences in ...O, Nov. 4 Orexigen(R) Therapeutics,Inc. (Nasdaq: ...e treatment,of obesity and other central nervous s...uarter 2008 financial results,as well as upcoming ...
Other Medicine News:Health News:Folic acid, B vitamins do not appear to affect cancer risk 2Health News:Vion Updates Conference Call Information 2Health News:Vion Updates Conference Call Information 3Health News:International Medical Corps Continues Delivering Emergency Relief in Democratic Republic of Congo as Potential for Renewed Fighting Threatens to Deepen Crisis 2Health News:Impact of insulin pump under study 2Health News:Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008 2
(Date:11/25/2009)..., WEST PALM BEACH, Fla., Nov. 25 /PRNewswire-Fi...paired Americans, especially the 27 million living...ot be all that happy, says audiologist Cindy Beyer...A (Amex: EAR ), one of America,s largest hearing ...ve linked hearing loss to stress, frustration, and...
(Date:11/25/2009)... , HARBIN, China, Nov. 25 /PRNewswire-Asi...a Sky One Medical" or "the Company") (Nasdaq: CSK...pany developing and producing,over-the-counter dru...y,announced that the Company recently passed the C...aceutical and Biological Products ("ICPBP") examin...
(Date:11/25/2009)... , EAST BRUNSWICK, N.J., Nov. 25 /PRNewswire/ -...rer of direct digital Radiography ( ddR ) systems,...uired by a private Swiss Investor with a long term...rand. The acquisition included all assets and inte...ory. After 25 years of success and growth Swissray...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Swissray International Announces New Ownership 2Webinar Offers Tips for Meeting Compliance Communications and Provides HRCI Credit for Human Resource Professionals 53413 1Webinar Offers Tips for Meeting Compliance Communications and Provides HRCI Credit for Human Resource Professionals 53413 2Webinar Offers Tips for Meeting Compliance Communications and Provides HRCI Credit for Human Resource Professionals 53413 3Swine Flu Advice from Confused com 53410 1Swine Flu Advice from Confused com 53410 2Swine Flu Advice from Confused com 53410 3Benefits from upper airway surgery for sleep apnea found to equal CPAP 53407 1
... Phase I Report from Trial of Quadramet in Combina... Refractory Multiple Myeloma. , , LOS ANGELES, Fe...a radioactive medication that targets the bone, sp...caused by cancer that has metastasized or spread t...for the treatment of multiple myeloma alone and in...
...- , , PLYMOUTH MEETING, Pa., Feb. 10 Genaera Cor...g preliminary Phase 1b clinical data for trodusque...ive inhibitor of PTP1B and Genaera,s lead drug can...esity. Mr. Jack Armstrong, President and CEO of G...orts in an ascending multiple dose study of MSI-14...
Other Medicine Technology:Phase 1 Trial of Quadramet in Combination with Velcade Shows Positive Results 2Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436) 2Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436) 3
...d has been developing diverse medical products for... have earned an outstanding reputation for innovat...lds internationally recognized brands include the ...o® medical sundry products, Bristoline® mi...
...llest nebulizer utilizing Vibrating Mesh Technolog...patients suffering from Asthma, COPD or other resp...product size and handy carrying case that is easil...elivery comparable to table-top compressor nebuliz...
...reg; Air Entrainment Nebulizers deliver particulat...onic secretion patients. For your convenience, The...ting supply of sterile water., ,The P30000N, for ... with a total flow range of 68-24 lpm. For your hi...
...y of medication as well as humidification, try Flo... closed dilution, high volume, continuous medicati...alation therapy to patients. Its 200 ml reservoir ...ulized medication delivery at 25 ml/hr. Particles ...
Medicine Products: